The makers of mifepristone, which is part of a two-drug regimen often called “the abortion pill,” asked the Supreme Court on May 2 to allow the prescription medication to be sent in the mail after a lower court blocked it.
The application for an emergency stay was filed one day after the U.S. Court of Appeals for the Fifth Circuit paused a Food and Drug Administration rule that allowed the abortion drug to be mailed.





